Feb. 27 (Bloomberg) -- An artificial pancreas device can help control the level of blood-sugar in young diabetics at night, when the most severe declines tend to occur, better than a standard method, a study shows.
As many as 56 patients 10 to 18 years old and suffering from type 1 diabetes were tested with the MD-Logic artificial pancreas made by researchers and, on alternate nights, an insulin pump linked to a glucose sensor. There were 7 events of night-time hypoglycemia as defined by European guidelines with the experimental device and 22 with the pump, according to the study published in the New England Journal of Medicine.
Sanofi, maker of the insulin Lantus, helped fund the research.
To contact the reporter on this story: Marthe Fourcade in Paris at firstname.lastname@example.org
To contact the editor responsible for this story: David Risser at email@example.com